Status | Study |
Recruiting |
Study Name: Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome Condition: Birt-Hogg-Dube Syndrome Date: 2017-01-05 Interventions: Other: Non-Interventional Study |
Recruiting |
Study Name: Prevalence of Spontaneous Pneumothorax in BHD Condition: Spontaneous Pneumothorax Date: 2016-01-23 Interventions: Radiation: CT scan of the thorax |
Recruiting |
Study Name: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer Condition: Renal Cancer Chromophobe Renal Cell Carcinoma Date: 2015-07-21 Interventions: Drug: Everolimus Everolimus is a commercial agent and is supplied by Novartis. |
Completed |
Study Name: Topical Rapamycin for Fibrofolliculomas Condition: Birt-Hogg-Dubé Syndrome Date: 2009-06-25 Interventions: Drug: Rapamycin Application of |
Recruiting |
Study Name: Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer Condition: Kidney Neoplasms Kidney Cancer Pneumothorax Date: 2002-04-05 |